Eiger BioPharmaceuticals, Inc.
Pharmaceutical compositions comprising lonafarnib and ritonavir

Abstract:

Lonafarnib and ritonavir, or a pharmaceutically acceptable salt thereof, are used in combination to treat HDV infection. In one aspect, amorphous co-precipitates comprising lonafarnib, ritonavir, and a co-polymer are provided.